Impact of Wuzi Yanzong (WZYZ) Formula on Semen Quality in Men with Sub-optimal Parameters: A Double-Blinded, Placebo-Controlled, Randomized Trial

This dataset contains data from a double-blinded, randomized, placebo-controlled clinical trial conducted at a large teaching hospital in Hong Kong. The study aimed to evaluate the effects of Wuzi Yanzong (WZYZ) formula, a Traditional Chinese Medicine, on semen quality, sperm function, and reproductive outcomes in men with suboptimal semen parameters, as defined by WHO (5th edition) criteria. Study Design: • Study Period: February 2018 – December 2022 • Sample Size: 153 men with suboptimal semen parameters • Randomization: Treatment group (WZYZ formula) vs. Placebo group • Intervention: WZYZ formula or placebo, taken twice daily for 12 weeks • Follow-up: • Semen analysis at baseline, 6 weeks, 3 months, and 6 months

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-28
DOI
https://doi.org/10.5281/zenodo.14942154
Primary Topic
Sperm and Testicular Function
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Wuzi Yanzong (WZYZ) Formula on Semen Quality in Men with Sub-optimal Parameters: A Double-Blinded, Placebo-Controlled, Randomized Trial

Zenodo (CERN European Organization for Nuclear Research)
Sperm and Testicular Function
article

Impact of Wuzi Yanzong (WZYZ) Formula on Semen Quality in Men with Sub-optimal Parameters: A Double-Blinded, Placebo-Controlled, Randomized Trial

article en

Abstract

This dataset contains data from a double-blinded, randomized, placebo-controlled clinical trial conducted at a large teaching hospital in Hong Kong. The study aimed to evaluate the effects of Wuzi Yanzong (WZYZ) formula, a Traditional Chinese Medicine, on semen quality, sperm function, and reproductive outcomes in men with suboptimal semen parameters, as defined by WHO (5th edition) criteria. Study Design: • Study Period: February 2018 – December 2022 • Sample Size: 153 men with suboptimal semen parameters • Randomization: Treatment group (WZYZ formula) vs. Placebo group • Intervention: WZYZ formula or placebo, taken twice daily for 12 weeks • Follow-up: • Semen analysis at baseline, 6 weeks, 3 months, and 6 months

Zenodo (CERN European Organization for Nuclear Research)
Chinese University of Hong Kong (HK)
Openalex Percentile: Top 47%
Sperm and Testicular Function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.